Henryk Mach

Title: Innovations in HPV Vaccines by Henryk Mach

Introduction

Henryk Mach is an accomplished inventor based in Ambler, PA (US). He has made significant contributions to the field of vaccine development, particularly focusing on human papillomavirus (HPV) vaccines. With a total of 2 patents, his work has the potential to enhance public health outcomes.

Latest Patents

Henryk Mach's latest patents include innovative formulations for HPV vaccines. One of his patents describes new human papillomavirus vaccine formulations that exhibit enhanced long-term stability. These formulations can include virus-like particles (VLPs) absorbed onto aluminum, a salt, non-ionic surfactant, and a buffer. Additionally, some formulations contain a polymeric polyanionic stabilizer and a salt, either in the presence or absence of buffering agents and nonionic detergent. Another patent focuses on a human papillomavirus vaccine that utilizes disassembled and reassembled virus-like particles. This approach aims to improve the stability and shelf-life of the vaccine by treating the VLPs through a disassembly and reassembly process. The patent also provides formulation buffers for the long-term stable storage of VLPs.

Career Highlights

Henryk Mach is currently associated with Merck & Co., Inc., a leading pharmaceutical company known for its commitment to research and development in healthcare. His work at Merck has allowed him to contribute to groundbreaking advancements in vaccine technology.

Collaborations

Henryk has collaborated with notable colleagues such as Li Shi and David B. Volkin. Their combined expertise has furthered the development of innovative vaccine formulations.

Conclusion

Henryk Mach's contributions to HPV vaccine formulations demonstrate his commitment to improving vaccine stability and efficacy. His innovative work has the potential to make a significant impact on public health.